Johnson & JohnsonJNJEarnings & Financial Report
NYSE · Health Care · Pharmaceuticals
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42th in the Forbes Global 2000.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| S.S. OR | 17.00% | 4.1M | ▲ +8.40pp | 2024-11-01 |
| The Vanguard Group | 9.53% | 229.4M | — | 2024-02-13 |
| BlackRock, Inc. | 7.70% | 186.3M | — | 2024-01-26 |
| STATE STREET CORPORATION | 5.52% | 478.2M | — | 2024-01-30 |
Insider Transactions
Net 90d: −$80.48M · buys $0 / sells $80.48MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Option exercise | 4.1K | $115.67 | $471.4K |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Sell (open market) | 4.1K | $247.87 | $1.01M |
| 2026-02-20 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 1.3K | $245.66 | $324.8K |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Option exercise | 13.6K | $115.67 | $1.58M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 13.6K | $244.20 | $3.33M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Option exercise | 9.0K | $129.51 | $1.17M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 9.0K | $244.53 | $2.20M |
| 2026-02-17 | Swanson James D. | EVP, CIO | Option exercise | 20.5K | $164.62 | $3.38M |
| 2026-02-17 | Swanson James D. | EVP, CIO | Sell (open market) | 20.5K | $242.70 | $4.98M |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Option exercise | 19.2K | $115.67 | $2.23M |
1–10 of 74
Page 1 / 8